This study found abnormal expression of SFPQ in patients with AS, and previous studies have found that regulating the SFPQ-AKT-RUNx2 pathway can reduce chondrocyte injury and the progression of osteoarthritis (55). This evidence concerns the gene AKT1 and osteoarthritis.